Gastric Cancer Patients with Bone Marrow Metastasis: A Single-Center Experience and Review of the Literature
Objectives: The purpose of this study is to investigate bone marrow metastasis in patients with Gastric cancer.
Methods: We retrospectively evaluated patients with gastric cancer who applied to our clinic between 2010-2016.
Results: 896 patients with gastric cancer were included in the study. Patients had metastatic bone marrow in 8 patients. When the laboratory results were evaluated; in 5 patients trombocytopenia with anemia were present, 2 patients had only tromboscytopenia, one patient had only anemia. In all patients white blood cell count was within normal range. The median survival of the 8 patients in our study was 72 days. In our chemoteraphy group (6 patients) median survival was 77 days (range, 49 to 145 days), in the non-treatment group was 7,5 days (range, 3 to 12 days).
Conclusion: Gastric cancer with bone marrow metastasis is usually seen in younger patients, and is related to poorly differantiated subtypes and is a disease with worse prognosis. Median survival with paliative chemotraphy is under 3 months.
1.Stewart BW, Wild CP. World Cancer Report 2014. Availble at: http://publications.iarc.fr/Non-Series-Publications/ World-Cancer-Reports/World-Cancer-Report-2014. Accessed Sep 28, 2017.
2. Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget 2016;7:52307–16. [CrossRef]
3. Anner RM, Drewinko B. Frequency and significance of bone marrow involvement by metastatic solid tumors. Cancer 1977;39:1337–44. [CrossRef]
4. Kiliçkap S, Erman M, Dinçer M, Aksoy S, Harputluoglu H, Yalçin S. Bone marrow metastasis of solid tumors: Clinicopathological evaluation of 73 cases. Turk J Cancer 2007;37:85–8.
5. Mohanty SK, Dash S. Bone marrow metastasis in solid tumors. Indian J Pathol Microbiol 2003;46:613–6.
6. Mehdi SR, Bhatt ML. Metastasis of solid tumors in bone marrow: a study from northern India. Indian J Hematol Blood Transfus 2011;27:93–5. [CrossRef]
7. Kucukzeybek BB, Calli AO, Kucukzeybek Y, Bener S, Dere Y, Dirican A, et al. The prognostic significance of bone marrow metastases: evaluation of 58 cases. Indian J Pathol Microbiol 2014;57:396–9. [CrossRef]
8. Kusumoto H, Haraguchi M, Nozuka Y, Oda Y, Tsuneyoshi M, Iguchi H. Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer: the pathogenesis of bone destruction. Oncol Rep 2006;16:735–40. [CrossRef]
9. Kim HS, Yi SY, Jun HJ, Lee J, Park JO, Park YS, et al. Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology 2007;73:192–7. [CrossRef]
10. Kwon JY, Yun J, Kim HJ, Kim KH, Kim SH, Lee SC, et al. Clinical outcome of gastric cancer patients with bone marrow metastases. Cancer Res Treat 2011;43:244–9. [CrossRef]
11. Ekinci AŞ, Bal O, Ozatlı T, Türker I, Eşbah O, Demirci A, et al. Gastric carcinoma with bone marrow metastasis: a case series. J Gastric Cancer 2014;14:54–7. [CrossRef]
12. Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Stomach Cancer. National Cancer Institute. Available at http://seer.cancer.gov/statfacts/html/stomach. html. Accessed May 21, 2015.
13. Glimelius B, Ekström K, Hoffman K, Graf W, Sjödén PO, Haglund U, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997;8:163–8. [CrossRef]
14. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006;24:4991–7. [CrossRef]
15. Turkoz FP, Solak M, Kilickap S, Ulas A, Esbah O, Oksuzoglu B, et al. Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival. J Gastric Cancer 2014;14:164–72. [CrossRef]
16. Xiao L, Luxi S, Ying T, Yizhi L, Lingyun W, Quan P. Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples. J Cancer Res Clin Oncol 2009;135:687–93. [CrossRef]
17. Ozkalemkas F, Ali R, Ozkocaman V, Ozcelik T, Ozan U, Ozturk H, et al. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer 2005;5:144. [CrossRef]